{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:01Z","timestamp":1791308821429,"version":"4.3.1"},"reference-count":33,"publisher":"Japanese Society of Veterinary Science","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1292\/jvms.12-0007","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T03:10:23Z","timestamp":1334286623000},"page":"1015-1022","source":"Crossref","is-referenced-by-count":17,"title":["Spironolactone, but not Eplerenone, Impairs Glucose Tolerance in a Rat Model of Metabolic Syndrome"],"prefix":"10.1292","volume":"74","author":[{"given":"Tsuyoshi","family":"HOMMA","sequence":"first","affiliation":[{"name":"Department of Veterinary Pharmacology, Faculty of Agriculture, University of Miyazaki"},{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd."},{"name":"Department of Veterinary Pharmacology, Faculty of Agriculture, University of Miyazaki, 1\u20131 Gakuenkibanadai-nishi, Miyazaki-shi, Miyazaki, 889\u20132192, Japan"},{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd., 1\u20132\u201358 Hiromachi, Shinagawa-ku, Tokyo 140\u20138710, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"FUJISAWA","sequence":"additional","affiliation":[{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd."},{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd., 1\u20132\u201358 Hiromachi, Shinagawa-ku, Tokyo 140\u20138710, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"ARAI","sequence":"additional","affiliation":[{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd."},{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd., 1\u20132\u201358 Hiromachi, Shinagawa-ku, Tokyo 140\u20138710, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"ISHII","sequence":"additional","affiliation":[{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd."},{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd., 1\u20132\u201358 Hiromachi, Shinagawa-ku, Tokyo 140\u20138710, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"SADA","sequence":"additional","affiliation":[{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd."},{"name":"Biological Research Laboratories, R&D Division, Daiichi-Sankyo Co., Ltd., 1\u20132\u201358 Hiromachi, Shinagawa-ku, Tokyo 140\u20138710, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"IKEDA","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pharmacology, Faculty of Agriculture, University of Miyazaki"},{"name":"Department of Veterinary Pharmacology, Faculty of Agriculture, University of Miyazaki, 1\u20131 Gakuenkibanadai-nishi, Miyazaki-shi, Miyazaki, 889\u20132192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Auchus, R. J. and Nwariaku, F. E. 2007. Primary aldosteronism. Curr. Cardiol. Rep. 9: 447–452.","DOI":"10.1007\/BF02938388"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.48"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bhathena, S. J., Kennedy, B. W., Jones, J., Smith, P. M., Michaelis, O. E. 4th, Carswell, N., Hansen, C. T., Voyles, N. R. and Recant, L. 1989. Effect of dietary carbohydrates on insulin and glucagon receptors in a new model of noninsulin-dependent diabetes-SHR\/N-corpulent rat. Proc. Soc. Exp. Biol. Med. 192: 66–71.","DOI":"10.3181\/00379727-192-42957"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-011-0182-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Caprio, M., Antelmi, A., Chetrite, G., Muscat, A., Mammi, C., Marzolla, V., Fabbri, A., Zennaro, M. C. and Feve, B. 2011. Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. Endocrinology 152: 113–125.","DOI":"10.1210\/en.2010-0674"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000259805.18468.8c"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-003-0065-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Davies, J. I., Band, M., Morris, A. and Struthers, A. D. 2004. Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes. Diabetologia 47: 1687–1694.","DOI":"10.1007\/s00125-004-1510-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Delyani, J. A., Rocha, R., Cook, C. S., Tobert, D. S., Levin, S., Roniker, B., Workman, D. L., Sing, Y. L. and Whelihan, B. 2001. Eplerenone: a selective aldosterone receptor antagonist (SARA). Cardiovasc. Drug Rev. 19: 185–200.","DOI":"10.1111\/j.1527-3466.2001.tb00064.x"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.103580"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G. and Mulatero, P. 2006. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J. Clin. Endocrinol. Metab. 91: 454–459.","DOI":"10.1210\/jc.2005-1733"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00959.x"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.748640"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvp191"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.3109\/03602537808993782"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Levine, D., Ramsay, L., Auty, R., Branch, R. and Tidd, M. 1976. Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone. Eur. J. Clin. Pharmacol. 09: 381–386.","DOI":"10.1007\/BF00606552"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Livingstone, C. and Collison, M. 2002. Sex steroids and insulin resistance. Clin. Sci. 102: 151–166.","DOI":"10.1042\/cs1020151"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mehdi, U. F., Adams-Huet, B., Raskin, P., Vega, G. L. and Toto, R. D. 2009. Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J. Am. Soc. Nephrol. 20: 2641–2650.","DOI":"10.1681\/ASN.2009070737"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1021\/jm100505n"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Michaelis, O. E. 4th, Ellwood, K. C., Judge, J. M., Schoene, N. W. and Hansen, C. T. 1984. Effect of dietary sucrose on the SHR\/N-corpulent rat: a new model for insulin-independent diabetes. Am. J. Clin. Nutr. 39: 612–618.","DOI":"10.1093\/ajcn\/39.4.612"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080944"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.10285FP"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-003-0065-2"},{"key":"24","unstructured":"24. Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J. and Gatlin, M. 2003. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348: 1309–1321."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J. and Wittes, J. 1999. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341: 709–717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Preiss, D., Zetterstrand, S., McMurray, J. J., Ostergren, J., Michelson, E. L., Granger, C. B., Yusuf, S., Swedberg, K., Pfeffer, M. A., Gerstein, H. C. and Sattar, N. 2009. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care 32: 915–920.","DOI":"10.2337\/dc08-1709"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ramsay, L. E., Hessian, P. and Tidd, M. J. 1975. Bioassay of aldosterone antagonists in normal human subjects: a relationship between the level of plasma uric acid before treatment and apparent drug responses. Br. J. Clin. Pharmacol. 2: 271–276.","DOI":"10.1111\/j.1365-2125.1975.tb01587.x"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20324"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1038\/ng1096-130"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wada, T., Hori, S., Sugiyama, M., Fujisawa, E., Nakano, T., Tsuneki, H., Nagira, K., Saito, S. and Sasaoka, T. 2010. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 298: E881–E888.","DOI":"10.1152\/ajpendo.00649.2009"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0869"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.04.024"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Zannad, F., McMurray, J. J., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J. and Pitt, B. 2011. Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med. 364: 11–21.","DOI":"10.1056\/NEJMoa1009492"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/74\/8\/74_12-0007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T01:07:58Z","timestamp":1617066478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/74\/8\/74_12-0007\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.12-0007","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}